143: Why Gum Disease Raises Your Blood Sugar

Bikman frames oral hygiene as a metabolic health practice, not just dental. The mouth houses 700 bacterial species; healthy gums form a tight cuff that acts as a barrier. When gums become inflamed and ulcerated (periodontitis), even chewing can force bacteria into the blood—a process called bacteremia. This leads to endotoxemia (LPS) and cytokine spillover, directly impairing insulin signaling. Daily brushing and flossing physically disrupt the biofilm, lowering the load of pathogenic bacteria and LPS. Combined with dietary carb control, this helps maintain the gum barrier, preventing a 'slow leak' of bacteria and toxins. He assigns 'floss your teeth today' as homework to reinforce this habit.

Bikman highlights strong evidence from intervention trials: a Cochrane review and multiple RCTs demonstrate that scaling and root planing significantly lowers HbA1c in people with diabetes. The procedure removes bacterial deposits below the gumline, directly attacking the source of systemic inflammation. He criticizes the healthcare silo where endocrinologists rarely inquire about periodontal status, so patients must self-advocate. He urges taking gum disease seriously not just for oral health but as a key lever to improve metabolic and cardiovascular outcomes.

Bikman connects diet to the oral microbiome: refined carbs feed pathogenic species, which then produce acids that directly damage gums and teeth, exacerbating periodontitis. This is a local effect independent of systemic metabolic responses. Reducing rapidly fermentable carbohydrates deprives these bacteria of fuel, helping preserve the gum barrier and prevent bacteremia. He positions this dietary shift as one pillar—alongside hygiene and professional care—for preventing the oral-to-systemic inflammation cascade.

Bikman credits David Diamond for this insight. LPS from P. gingivalis enters the bloodstream and binds to LDL, which neutralizes its inflammatory potential. This binding prevents LPS from activating toll-like receptors and triggering cytokine release. Bikman points out that people with very low LDL levels are far more susceptible to severe infections like sepsis, suggesting LDL is part of the immune defense. He argues that the presence of LDL at an atherosclerotic plaque might not signify causation but rather a response to contain the inflammatory damage caused by bacterial endotoxins. He uses a fire truck analogy: seeing a fire truck at every burning building might lead one to erroneously conclude the truck causes the fire, when in fact it is there to fight it. Similarly, LDL may be deployed to control the inflammatory fire.

Bikman's lab, with dental students and undergraduates, treated human gingival cells with P. gingivalis LPS. They observed that mitochondria consumed more oxygen—breathing harder—yet produced far less ATP. The excess oxygen was diverted to create reactive oxygen species, driving oxidative stress. Additionally, the mitochondria underwent increased fission, fragmenting under the noxious stimulus. This cellular-level damage in gum tissue contributes to local and systemic inflammation, weakening energy metabolism and amplifying oxidative burden. The finding underscores how periodontal pathogens directly sabotage cellular energy production, beyond just immune activation.

Bikman cites a Cochrane review of 35 RCTs involving over 3,000 participants, finding a reduction of about 0.5 percentage points in HbA1c after periodontal treatment. Other meta-analyses show reductions from 0.4 to 0.7. He compares this to some diabetes drugs that advertise similar A1C reductions but carry side effects. The treatment, scaling and root planing, removes bacterial deposits below the gumline, reducing bacterial and endotoxin burden. He argues that dental visits should be integrated into diabetes management, as this evidence makes a strong case for treating the mouth to improve systemic glycemic control.

Bikman cites longitudinal data from Japan showing that severity of periodontal disease independently predicted progression to glucose intolerance in individuals with normal baseline blood markers. Cross-sectional analyses from multiple countries found that even after controlling for age, sex, BMI, smoking, and exercise, severe periodontitis was associated with higher HOMA-IR scores, higher triglycerides, and abdominal obesity. The odds of severe periodontitis were about 50% higher in people with type 2 diabetes compared to those with normal glucose tolerance. Crucially, the association held in non-abdominally obese adults, meaning gum disease can cause insulin resistance without excess body fat. This evidence reframes oral inflammation as an independent contributor to metabolic disease.